Table 3.
KEGG pathways of genes not differentially expressed during kidney development.
| KEGG Pathways | Genes | Gene Set | z-score |
|---|---|---|---|
| Adherens junction | 38 | 64 | 2.03 |
| Alzheimer’s disease | 78 | 130 | 3.07 |
| Autoimmune thyroid disease | 12 | 39 | −2.02 |
| Complement and coagulation cascades | 17 | 59 | −2.8 |
| Cytokine-cytokine receptor interaction | 54 | 164 | −3.65 |
| Drug metabolism - cytochrome P450 | 16 | 49 | −2 |
| Endocytosis | 101 | 158 | 4.41 |
| Gap junction | 28 | 79 | −2.05 |
| Glycine, serine and threonine metabolism | 15 | 22 | 2.01 |
| Hematopoietic cell lineage | 14 | 51 | −2.79 |
| Insulin signaling pathway | 63 | 107 | 2.54 |
| MAPK signaling pathway | 109 | 201 | 2.17 |
| Metabolism of xenobiotics by cytochrome P450 | 12 | 46 | −2.84 |
| N-Glycan biosynthesis | 23 | 36 | 2.06 |
| Neuroactive ligand-receptor interaction | 57 | 165 | −3.24 |
| Neurotrophin signaling pathway | 62 | 102 | 2.87 |
| Other glycan degradation | 9 | 11 | 2.33 |
| Parkinson’s disease | 56 | 94 | 2.51 |
| Prostate cancer | 46 | 79 | 2.05 |
| Proteasome | 25 | 36 | 2.73 |
| Pyrimidine metabolism | 39 | 64 | 2.28 |
| Renal cell carcinoma | 39 | 63 | 2.42 |
| Retinol metabolism | 9 | 34 | −2.39 |
| Small cell lung cancer | 44 | 73 | 2.33 |
| Steroid hormone biosynthesis | 7 | 35 | −3.2 |
| Systemic lupus erythematosus | 28 | 80 | −2.14 |
| Thyroid cancer | 18 | 27 | 2.07 |
| Tyrosine metabolism | 8 | 30 | −2.22 |
| Ubiquitin mediated proteolysis | 61 | 107 | 2.14 |
| VEGF signaling pathway | 37 | 55 | 3.06 |
| Wnt signaling pathway | 63 | 108 | 2.43 |